PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)
CUSIP: 74587V107
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,633,071
- Total 13F shares
- 35,087,132
- Share change
- -1,505,665
- Total reported value
- $365,869,787
- Put/Call ratio
- 211%
- Price per share
- $10.43
- Number of holders
- 124
- Value change
- -$6,707,284
- Number of buys
- 71
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74587V107:
Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.3%
|
4,634,697
|
$39,117,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
7.1%
|
3,539,620
|
$29,874,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.7%
|
2,815,883
|
$23,766,000 | — | 31 Mar 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
5.1%
|
2,536,156
|
$21,405,000 | — | 31 Mar 2020 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
4.7%
|
2,334,967
|
$19,707,000 | — | 31 Mar 2020 | |
| Camber Capital Management LP |
13F
|
Company |
3.9%
|
1,950,000
|
$16,458,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.9%
|
1,947,825
|
$16,440,000 | — | 31 Mar 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
2.8%
|
1,396,163
|
$11,784,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.2%
|
1,088,597
|
$9,188,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
1,035,611
|
$8,741,000 | — | 31 Mar 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2%
|
1,008,897
|
$8,515,000 | — | 31 Mar 2020 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.9%
|
963,212
|
$8,130,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.8%
|
875,265
|
$7,388,000 | — | 31 Mar 2020 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.6%
|
800,000
|
$6,752,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
693,453
|
$5,853,000 | — | 31 Mar 2020 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.3%
|
638,026
|
$5,385,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
546,058
|
$4,608,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.97%
|
479,528
|
$4,047,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.95%
|
472,437
|
$3,987,000 | — | 31 Mar 2020 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.94%
|
466,482
|
$3,937,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
380,018
|
$3,208,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
0.65%
|
321,802
|
$2,716,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
309,762
|
$2,615,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
244,068
|
$2,060,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.46%
|
227,300
|
$1,918,000 | — | 31 Mar 2020 | |
| PDT Partners, LLC |
13F
|
Company |
0.41%
|
204,238
|
$1,724,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.38%
|
188,763
|
$1,593,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
170,596
|
$1,440,000 | — | 31 Mar 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.38%
|
190,838
|
$1,403,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.33%
|
164,497
|
$1,388,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
164,521
|
$1,387,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.31%
|
156,093
|
$1,317,000 | — | 31 Mar 2020 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.3%
|
149,243
|
$1,260,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.3%
|
149,089
|
$1,258,000 | — | 31 Mar 2020 | |
| Capital Impact Advisors, LLC |
13F
|
Company |
0.3%
|
147,303
|
$1,243,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.28%
|
137,444
|
$1,159,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.26%
|
129,427
|
$1,094,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.25%
|
122,868
|
$1,037,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
104,117
|
$880,000 | — | 31 Mar 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
102,431
|
$864,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.18%
|
91,068
|
$768,000 | — | 31 Mar 2020 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.17%
|
84,209
|
$711,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.17%
|
83,445
|
$704,000 | — | 31 Mar 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.17%
|
82,200
|
$703,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.16%
|
80,500
|
$679,000 | — | 31 Mar 2020 | |
| Trexquant Investment LP |
13F
|
Company |
0.16%
|
79,050
|
$667,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.16%
|
77,794
|
$657,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.15%
|
73,932
|
$623,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
73,299
|
$619,000 | — | 31 Mar 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
71,500
|
$603,000 | — | 31 Mar 2020 |
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2020
As of 30 Jun 2020,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
124 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,087,132 shares.
The largest 10 holders included
VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., FRED ALGER MANAGEMENT, LLC, Camber Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, TANG CAPITAL MANAGEMENT LLC, Palo Alto Investors LP, ACADIAN ASSET MANAGEMENT LLC, and Sofinnova Investments, Inc..
This page lists
124
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
121
Q2 2020 holders
124
Holder diff
3
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.